Johnson & Johnson Vision is announcing a series of breakthrough data, technology, and products at the upcoming 2019 American Academy of Ophthalmology (AAO) annual meeting in San Francisco. The company will be announcing the FDA approval of the iDESIGN Refractive Studio Wavefront-guided PRK indication and the availability of Tecnis Simplicity Delivery System.
“Innovation comes in many forms—ranging from products and treatment techniques, to innovations that make practice management easier so that ophthalmologists can focus on the work that matters most—helping patients see better, connect better, live better,” Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision, said in a company news release. “As a global leader in eye health, we’re moving the needle on all these fronts. At AAO, we are announcing our new IOL insertion system Tecnis Simplicity, adding a PRK indication to our industry-leading iDESIGN Refractive Studio, and introducing CHiME Manage, a new innovation in inventory management.”
Tecnis Simplicity Delivery System
Tecnis Simplicity Delivery System, now FDA-approved, is a new preloaded, fully disposable intraocular lens delivery system that is designed to prevent loading errors, simplify lens delivery, and protect against contamination to help elevate the standard of care for patients when paired with a Tecnis 1-piece IOL.1
“The Tecnis Simplicity makes preloaded delivery simple and efficient for all the team members in the operating room. In my own experience, preloaded lens technology has improved my efficiency and care for patients during cataract surgery,” Preeya Gupta, MD, Corneal Specialist at Duke University Eye Center, said in the news release. The Tecnis 1-piece IOL is now available preloaded in the Tecnis Simplicity Delivery System in the United States.
New Data & FDA Approval for Wavefront-Guided PRK Indication for iDESIGN Refractive Studio
The FDA has approved the use of Wavefront-Guided PRK for the iDESIGN Refractive Studio, expanding options for surgeons across LASIK, PRK and monovision procedures. New clinical data being presented at AAO, raises the bar for the industry in visual acuity outcomes and patient satisfaction for the WFG-PRK procedure2:
- 99% of patients achieved 20/16 or better binocular uncorrected visual acuity (UCVA) at six-months postop
- 99% of subjects reported being very satisfied to completely satisfied with their vision 6-months postop
“The FDA approval makes the iDESIGN Refractive Studio the first and only system with a Wavefront-Guided PRK indication. This expands a patient’s options for truly personalized laser vision correction, and opens the door for wider adoption of this amazing technology,” Christopher Blanton, MD, President of Inland Eye Institute in Colton, California, said in the news release.
The new software will be commercially available in the first quarter of 2020.
New Offerings for Eye Care Professionals to Aid in Practice Management
Johnson & Johnson Vision is announcing CHiME, a new program committed to allowing ophthalmologic practices the freedom to focus on what matters most–patient care. CHiME tests and launches offerings for today’s busy practices with a goal of making their customer experience effortless.
Building on the unveiling of Customer Connect, a breakthrough e-commerce system launched earlier this year, Johnson & Johnson Vision is introducing CHiME Manage–an all-inclusive smart inventory management system that will automate the inventory process for its products, while also providing safeguards in patient care. CHiME Manage will help practices plan and optimize inventory utilization, streamline ordering, provide valuable insight with actionable reporting, reduce human picking errors, and assist in expiration management. The cabinet will be revealed at AAO and piloted in several practices across the U.S. this fall.
* The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.
†Drs. Preeya Gupta and Chris Blanton are paid consultants to Johnson & Johnson Surgical Vision.
ǂBased on FDA manufacturer excimer platform results, head to head studies, non-comparative studies, and podium abstracts & posters, iDESIGN has been shown to deliver 20/16 or better visual outcomes in majority of myopia patients. Data available upon request.
- TECNIS ® 1 IOL with TECNIS ® Simplicity TM Delivery System [DFU, package insert]. Santa Ana, Calif. Johnson & Johnson Surgical Vision. 2019.
- PMA P930016/S057: FDA Summary of Safety and Effectiveness Data